Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
about
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset.Oxidant/Antioxidant Imbalance in Alzheimer's Disease: Therapeutic and Diagnostic Prospects.Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging.
P2860
Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
@en
type
label
Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
@en
prefLabel
Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
@en
P2860
P356
P1476
Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
@en
P2093
P2860
P304
P356
10.3233/JAD-150826
P577
2016-01-19T00:00:00Z